Delivery Order SPE2DB22D2007-SPE2DB24FJ3YX

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The $10,841.67 contract has an ultimate completion date of April 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II VACCINE VIALS to the Defense Logistics Agency (DLA). The award, valued at $3,074.28, is a Firm Fixed Price Delivery Order contract with a completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,196.97 firm fixed price delivery order is for the supply of M-M-R II vaccine vials, with a period of performance through May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a wide range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The $6,457.02 firm fixed price delivery order has a completion date of May 8, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, including the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a $999,999,999.00 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract has a ceiling value of $1,537.14 and a completion date of May 31, 2024. It is a Firm Fixed Price delivery order contract, awarded without any set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,024.78 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a completion date of June 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corporation, through its Corporate Office division, is a delivery order valued at $1,537.14 for the supply of M-M-R II vaccine vials. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has a performance period through April 3, 2024. Amerisourcebergen Drug Corporation, a leading global pharmaceutical distribution company, serves as the prime contractor on...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The $14,346.64 firm-fixed-price delivery order was awarded on June 26, 2024, with a completion date of June 27, 2024. The award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a $1,458.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of M-M-R II vaccine vials, with a completion date of September 23, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various defense and civilian agencies through its extensive supply chain. The company holds several...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,334.30 firm fixed-price contract is for the supply of M-M-R II vaccine vials, with an ultimate completion date of August 7, 2024. Amerisourcebergen is a major pharmaceutical distributor in the United States, and this award is part of the company's extensive federal contracting activities to provide a wide range of essential medical commodities,...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3YX
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II vaccine vials. The $8,225.57 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of July 9, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 10/7/24, 11:01 AM